FDA
-
-
-
-
-
-
-
Evoke Pharma patent for GIMOTI nasal spray added to FDA Orange Book
-
-
-
-
-
-
-
Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTIĀ®
-
-
-
-
-
-
-
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
-
-
-
-
-
-
-
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
-
-
-
-
-
-
-
Evoke Pharma Announces Closing of $7.5 Million Public Offering
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

